ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1246

Causes and Predictors of Early Readmission in Systemic Lupus Erythematosus

Angelica Nangit1, Michael Weisman2, Mariko Ishimori2, Brennan Spiegel3 and Connie Lin4, 1Rheumatology, Cedars Sinai Medical Center, Reseda, CA, 2Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 3Gastroenterology; Health Policy and Management, Cedars-Sinai Health System and UCLA School of Medicine and Public Health, Los Angeles, CA, 4Internal Medicine, Cedars Sinai Medical Center, Los Angeles, CA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Lupus and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Health Services Research - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose : Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is largely heterogeneous and can affect virtually any organ system. Each year about one-third of individuals with SLE are hospitalized, and it is one of the highest rated causes of readmission in the United States. We took an in-depth look at SLE patients admitted to Cedars-Sinai Medical Center (CSMC) who required early readmission to assess whether there were any opportunities that could have prevented readmission, as well as identify which patients are at highest risk for readmission.

Methods : We performed a retrospective cohort study to look at inpatient records of SLE patients at CSMC between January 2012 and July 2014. We identified patients with SLE that were readmitted within 30 days of discharge and whose primary hospitalization included an ICD-9 diagnosis of SLE (710.0). These readmitted patients were compared to patients with lupus who did not require early readmission. Finally, we used stepwise logistic regression to calculate which variables were associated with early readmission.

Results : The study group included 154 patients in the early readmission group, and 301 patients in the group that was not readmitted. The main causes for early readmission included cardiovascular, renal, and infectious complications. Age and gender did not play a significant role, however the readmission group had significantly more African American patients and more patients with publicly funded insurance. Immunosuppressive use, key laboratory values such as low hemoglobin, elevated creatinine, and lower albumin were also associated with early readmission.

Conclusion: We found higher rates of readmission among African Americans and patients with MediCal insurance. We also found that elevated creatinine, low hemoglobin, and low albumin levels were associated with readmission. Immunosuppressive use also correlated with readmission. Data collected in this study will allow for identification of patients at highest risk for early readmission, which will provide an opportunity to improve the discharge process and transitions in care in the lupus patient population.

Number of patients in cohort

Readmitted

Not Readmitted

154

301


Disclosure: A. Nangit, None; M. Weisman, None; M. Ishimori, None; B. Spiegel, None; C. Lin, None.

To cite this abstract in AMA style:

Nangit A, Weisman M, Ishimori M, Spiegel B, Lin C. Causes and Predictors of Early Readmission in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/causes-and-predictors-of-early-readmission-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/causes-and-predictors-of-early-readmission-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology